Zobrazeno 1 - 10
of 489
pro vyhledávání: '"G. Theron"'
Publikováno v:
International Journal of Infectious Diseases, Vol 79, Iss , Pp 65-71 (2019)
Background: Data about the relationship between chest radiographs and sputum bacillary load, with treatment outcomes, in patients with extensively drug-resistant tuberculosis (XDR-TB) from HIV/TB endemic settings are limited. Methods: Available chest
Externí odkaz:
https://doaj.org/article/c8c1addf37ce4b4db63b82189596f884
Autor:
A.L. García-Basteiro, A. DiNardo, B. Saavedra, D.R. Silva, D. Palmero, M. Gegia, G.B. Migliori, R. Duarte, E. Mambuque, R. Centis, L.E. Cuevas, S. Izco, G. Theron
Publikováno v:
Pulmonology, Vol 24, Iss 2, Pp 73-85 (2018)
The goals of the End TB strategy, which aims to achieve a 90% reduction in tuberculosis (TB) incidence and a 95% reduction in TB mortality by 2035, will not be achieved without new tools to fight TB. These include improved point of care (POC) diagnos
Externí odkaz:
https://doaj.org/article/5ba24a203e904e4e9b8a576f32965cae
Autor:
M. de Vos, S. Ley, B. Derendinger, A. Dippenaar, M. Grobbelaar, A. Reuter, J. Daniels, S. Burns, G. Theron, J. Posey, R. Warren, H. Cox
Publikováno v:
Инфекция и иммунитет, Vol 8, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/b576d5e7b4694cc8bf7aa2fe3ed85af0
Autor:
A Heitkamp, J Suh, S Gebhardt, J van Roosmalen, L R Murray, J I de Vries, T van den Akker, G Theron
Publikováno v:
South African Medical Journal, Vol 112, Iss 9 (2022)
Background. To improve maternal health, studies of maternal morbidity are increasingly being used to evaluate the quality of maternity care, in addition to studies of mortality. While South Africa (SA) has a well-established confidential enquiry into
Externí odkaz:
https://doaj.org/article/8b48738debc444588f4f203fc21bbae7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
YT Ghebrekristos, N Beylis, CM Centner, R Venter, B Derendinger, H Tshivhula, S Naidoo, R Alberts, B Prins, A Tokota, T Dolby, FM Marx, SV Omar, R Warren, G Theron
BackgroundXpert MTB/RIF Ultra (Ultra) (Cepheid, Sunnyvale, USA) is a widely-used rapid front-line TB and rifampicin susceptibility test. Mycobacterium Growth Indicator Tube 960 (MGIT960) culture is still used as an adjunct for tuberculosis (TB) and d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28442be7c22eeee4f7114b3b7b17fbc7
https://doi.org/10.1101/2022.12.07.22283223
https://doi.org/10.1101/2022.12.07.22283223
BackgroundXpert MTB/RIF (Xpert) revolutionised tuberculosis (TB) diagnosis, however, laboratory decision making on whether widely-used reflex drug susceptibility assays (MTBDRplus, MTBDRsl) are done on specimens is often based on smear microscopy sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9762f73ac400c237df84aa012a69e580
https://doi.org/10.1101/2022.12.05.22283088
https://doi.org/10.1101/2022.12.05.22283088
Autor:
S. Huddart, L. Asege, D. Jaganath, M. Golla, H. Dang, L. Lovelina, B. Derendinger, A. Andama, D. J. Christopher, N. V. Nhung, G. Theron, C. M. Denkinger, P. Nahid, A. Cattamanchi, C. Yu
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 27:221-222
Autor:
B. Derendinger, A. Dippenaar, M. de Vos, S. Huo, R. Alberts, R. Tadokera, J. Limberis, F. Sirgel, T. Dolby, C. Spies, A. Reuter, M. Folkerts, C. Allender, A. Van Rie, S. Gagneux, L. Rigouts, J. te Riele, K. Dheda, D. Engelthaler, R. Warren, J. Metcalfe, H. Cox, G. Theron
IntroductionBedaquiline (BDQ) is a lifesaving new tuberculosis (TB) drug undergoing global scale-up. Data on resistance emergence in programmatic settings, especially in patients resistant to other drugs with potentially weak background regimens, is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb69c8d4c78f9ced47c2afb1696ec0f5
https://doi.org/10.1101/2022.11.14.22282167
https://doi.org/10.1101/2022.11.14.22282167